Brief: U.S. FDA Approves Nova Mentis Orphan Drug Application
02/11/2021 12:32
Nov 2 (Reuters) - Nova Mentis Life Science Corp NOVA.CD :
* U.S. FDA APPROVES NOVA MENTIS ORPHAN DRUG APPLICATION
Source text for Eikon: ID:nCNWCTTJsa
Further company coverage: NOVA.CD
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Restart Life Sciences
See all newsBrief: Nova Mentis Announces Closing Of Non-Brokered Financing
Brief: Nova Mentis Files Genetic Neuroinflammatory Disease Patent
Brief: U.S. FDA Approves Nova Mentis Orphan Drug Application
Brief: Nova Mentis Launches Autism Clinical Study
Brief: Nova Mentis Life Science Says Co Approved For Trading On OTCQB Venture Market Effective Mar. 10